NIH-funded research R01 grant

Understanding a Protein's Role in Abdominal Aortic Aneurysms

Official title: BAF60c and abdominal aortic aneurysm

Funded at University of Michigan at Ann Arbor · NIH-11112304 · Data updated 2026-11-12

This research looks into a specific protein called BAF60c to better understand how abdominal aortic aneurysms develop, hoping to find new ways to treat them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 1, 2021
Project endJune 30, 2027
Funding year2025
Award (this year)$543,752
NIH project number5R01HL153710-05
Project IDNIH-11112304 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is not directly recruiting patients but aims to benefit individuals at risk for or living with abdominal aortic aneurysms in the future.

Less likely to help

Patients seeking immediate treatment options or direct clinical intervention will not find direct benefit from this early-stage research.

What this research studies

Abdominal Aortic Aneurysm (AAA) is a serious condition where the main artery in your belly weakens and can rupture, and we currently lack effective drug treatments. This project aims to uncover the tiny, hidden processes within our cells that cause AAA to start and get worse. We are focusing on a specific group of proteins called BAF60, which seem to play a role in how blood vessel cells behave and how AAA develops. By understanding how these proteins work, especially BAF60c, we hope to discover new ways to create medications that can stop or slow down AAA.

Why it matters

Potential benefit: If successful, this work could lead to the development of new drug therapies to prevent or treat abdominal aortic aneurysms, offering a much-needed alternative to current options.

How similar studies have gone: Previous experimental work with a related protein, BAF60a, has shown promising results in preventing AAA in models, suggesting this approach has potential.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Zhang, Jifeng — University of Michigan at Ann Arbor
  • Study coordinator: Zhang, Jifeng

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.